| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 9,380 | 9,480 | 05.02. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Attendo Q4 2025 slides: EBITA surges 53%, sets ambitious 2028 EPS target | 2 | Investing.com | ||
| Do | Attendo steigert EBITDA um 53 % - Aktie reagiert mit Kurssprung | 1 | Investing.com Deutsch | ||
| Do | Attendo AB: Attendo's Year-End and fourth quarter report 2025: Strong fourth quarter and year - clear improvement in Scandinavia | 47 | GlobeNewswire (Europe) | Attendo ended 2025 with a strong fourth quarter and a positive trend in both our business areas. Higher occupancy, more accurate staffing planning and a continuing strong focus on quality combined to... ► Artikel lesen | |
| 28.10.25 | Attendo is changing its distribution channel for press releases | 3 | Cision News | ||
| ATTENDO Aktie jetzt für 0€ handeln | |||||
| 27.10.25 | Attendo AB: Attendo files claim against the city of Västerås after incorrect termination of home care contract | 202 | GlobeNewswire (Europe) | Attendo's view is that the City of Västerås had no basis for the termination of the home care agreement that occurred earlier this year. Attendo has also been informed that the preliminary investigations... ► Artikel lesen | |
| 27.10.25 | Attendo AB: Attendo divests its child welfare and family care operations in Finland | 267 | GlobeNewswire (Europe) | Attendo and Validia have signed an agreement whereby Attendo will divest its childcare and family care operations in Finland, with Validia as the new owner. The transaction is expected to close in the... ► Artikel lesen | |
| 27.10.25 | Ambea, through its Finnish business area Validia, has entered into an agreement to acquire Attendo's child welfare and family care services in Finland | 1 | Cision News | ||
| 24.10.25 | Attendo AB: Attendo's interim report for July-September 2025: The strongest quarter to date, driven by the development in Finland | 142 | GlobeNewswire (Europe) | Developments continued to be positive during the third quarter of the year, primarily driven by the Finnish operations and increased occupancy in nursing homes in both Finland and Scandinavia. The strong... ► Artikel lesen | |
| 23.09.25 | ATTENDO: Repurchases of shares during week 38, 2025 | 1 | Cision News | ||
| 18.09.25 | Attendo terminates Home Care contracts in Katrineholm and Nyköping | 2 | Cision News | ||
| 16.09.25 | ATTENDO: Repurchases of shares during week 37, 2025 | 1 | Cision News | ||
| 15.09.25 | Attendo has completed the acquisition of Främja AB - grows within LSS under the Unika brand | 1 | Cision News | ||
| 09.09.25 | ATTENDO: Repurchases of shares during week 36, 2025 | 3 | Cision News | ||
| 02.09.25 | ATTENDO: Repurchases of shares during week 35, 2025 | 1 | Cision News | ||
| 26.08.25 | ATTENDO: Repurchases of shares during week 34, 2025 | 2 | Cision News | ||
| 19.08.25 | ATTENDO: Repurchases of shares during week 33, 2025 | 1 | Cision News | ||
| 12.08.25 | ATTENDO: Repurchases of shares during week 32, 2025 | 1 | Cision News | ||
| 18.07.25 | Attendo AB: Attendo's Report For April-june 2025: Strong Quarter With Continued Earnings Growth | 412 | GlobeNewswire (Europe) | Attendo reports continued earnings growth, strong cash flow and high satisfaction among customers and employees in the second quarter of 2025. The results are mainly driven by the Finnish operations... ► Artikel lesen | |
| 08.05.25 | Dividendenbekanntmachungen (08.05.2025) | 12.825 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDNODE GROUP AB SE0017885767 1,15 SEK 0,1052 EUR AG BARR PLC GB00B6XZKY75 0,1376 GBP 0,1617 EUR ALANTRA PARTNERS SA ES0126501131 - 0... ► Artikel lesen | |
| 07.05.25 | Attendo AB: Attendo's First Quarter Report 2025: Strong Start To The Year Driven By Finland | 274 | GlobeNewswire (Europe) | Attendo reports a strong start to the year 2025, both operationally and financially. In Finland, the operating result continued to improve due to a fast adaptation to new staffing requirements, leading... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,600 | -0,47 % | Aktie leicht im Minus: Siemens Healthineers enttäuscht mit schwachem Start ins neue Geschäftsjahr | © Foto: Daniel Karmann/dpa Siemens Healthineers startet schwächer ins neue Geschäftsjahr. Während das Kerngeschäft wächst, belasten Währungseffekte und die schwierige Lage in China die Ergebnisse. Dennoch... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,480 | +0,52 % | Fresenius Medical Care AG: Das Übergangsjahr 2026 rückt zunehmend in den Fokus. KAUFEN. | Die jüngste Konsensaktualisierung von Fresenius Medical Care lenkt den Fokus auf das Geschäftsjahr 2026 als ein Übergangsjahr. Die Markterwartungen deuten auf eine schrittweise operative Erholung hin... ► Artikel lesen | |
| FRESENIUS | 49,240 | -0,32 % | Fresenius: Analysten bleiben bullish - jetzt einsteigen? | Der charttechnische Ausflug der Aktie des Gesundheitskonzerns Fresenius über die Marke von 50 Euro war nicht nachhaltig. Inzwischen notiert der DAX-Wert wieder deutlich darunter. Geht es nach dem Gros... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,360 | 0,00 % | BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 | ||
| HEARTFLOW | 25,970 | -7,71 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,340 | -1,23 % | BARCLAYS stuft CARL ZEISS MEDITEC AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Carl Zeiss Meditec von 49 auf 32 Euro gesenkt und die Aktien von "Overweight" auf "Equal Weight" abgestuft. Nur... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,400 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,150 | 0,00 % | 6 Analysts Have This To Say About Alignment Healthcare | ||
| GENEDX | 84,08 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 21,920 | -3,73 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GERRESHEIMER | 25,160 | +0,08 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Gerresheimer mit einem Kursziel von 34,10 Euro auf "Buy" belassen. Analyst James Vane-Tempest zählt den Spezialverpackungshersteller... ► Artikel lesen | |
| UNITEDHEALTH | 227,85 | -0,02 % | UnitedHealth: Das sieht gar nicht gut aus | Der enttäuschende Ausblick, den UnitedHealth dem Kapitalmarkt vor Kurzem an die Hand gegeben hat, und maue Aussichten für 2027 hinterlassen weitere Spuren im Aktienkurs des größten US-Krankenversicherers.... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,500 | -2,32 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| HIMS & HERS HEALTH | 19,945 | +0,13 % | Frontalangriff: Hatte Novo das auf der Rechnung? Hims kontert mit billiger Pillen-Variante! | © Foto: DALL-EWährend die Aktien von Hims mit einem zweistelligen Plus in den Handelstag startet, muss Novo Nordisk erneut kräftig Federn lassen. Die US-Pharmaplattform startet den Verkauf einer deutlich... ► Artikel lesen | |
| CLEARPOINT NEURO | 12,570 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen |